Sales of nonvascular interventional radiology devices are rapidly increasing to treat a range of complicated medical conditions. Manufacturers are coming up with diversified offerings in the form of Cope Gastrointestinal Suture, New Biopsy Needles, AccuStick, ESP Glove, Rösch-Thurmond Fallopian Tube Catheterization Set, etc. to enhance the quality of devices, which is likely to sustain the adoption of nonvascular interventional radiology devices.
NEWARK, DE / ACCESSWIRE / July 8, 2024 / The worldwide Nonvascular Interventional Radiology Device Market size is likely to reach USD 44.6 Billion by 2034, which was measured at a USD 27.6 Billion valuation mark in 2024. Owing to a CAGR of 4.9% through the forecast era, the ecosystem is likely to reach the abovementioned size.
The rising geriatric population is the fundamental factor that drives the sector. As the segment requires constant medical support and assistance, the demand for several diagnostics techniques is likely to increase in the future. This might be a key driver for the ecosystem, augmenting the size of the market.
The integration of technology like AI can augment the design and specifications of nonvascular interventional radiology devices. Accuracy and precision of test results can improve, which can leverage better diagnostics services. The reliance of healthcare professionals on the use of such modern technology is likely to elevate through the forecast period. The technological integration can lead to innovation, augmenting the size of the global nonvascular interventional radiology device market.
Request a Sample Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-9669
The growing trend of telehealth practices is expected to drive the ecosystem. Owing to the growing importance of remote patient assistance, the demand for telemedicine practices has increased. This can shape the size of the ecosystem. Novel devices are gaining momentum in the ecosystem, which is expected to create several prospects for key players in the sector. Such opportunities can also diversify the functioning of leading brands.
Key Takeaways from the Nonvascular Interventional Radiology Device Market Study:
The projected rate of the development of the nonvascular interventional radiology device market size in the United States is set to occur at a CAGR of % through 2034.
Compared to historical values, the progress of the ecosystem is likely to create better prospects for key players during the forecast period. Owing to CAGR of 3.6% and 4.9% for the respective eras, the competitive space is set to advance.
The estimated advancement of the industry in India is likely to adhere to the highest CAGR of 5.5% through the forecast period, creating several key opportunities for leading manufacturers in the country.
The Tier 1 category of the ecosystem possesses the highest industry share in 2024, followed by the Tier 2 category. Space occupied by two categories is 64.7% and 25.7% respectively in 2024.
"Owing to the high costs of nonvascular interventional radiology devices, the demand for such devices might reduce due to confined reach in the ecosystem. This is a key barrier to the growth of the sector," Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)
Nonvascular Interventional Radiology Device Market Competition Outlook
Owing to the growing technological infrastructure, key organizations in the Tier 1 category have been able to create a strong presence in the global landscape. Expansion of such organizations can be simplified due to such acquisitions as key players can mitigate changing consumer and industry trends more easily.
Apart from technological acquisitions, leading manufacturers in the landscape expand using different strategies, including partnerships, mergers, acquisitions, and strategic collaborations.
New entrants, on the other hand, might face barriers while entering the sector. To mitigate the threat of key players in the sector, new entrants are required to adhere to strategies like strategic alliances, innovation, and differentiation. Tier 1 and Tier 2 categories govern the progress of the worldwide nonvascular interventional radiology device market size: -
In January 2024, Carestream Health Inc. introduced a new DRX Excel Plus X-ray system. The system aims to elevate the productivity and deliver a better consumer experience.
In February 2024, Hologic Inc. announced the launch of the digital cytology system called Genius Digital Diagnostics System. This product launch helped the organization bolster its market position.
Purchase The Full Report Now: https://www.futuremarketinsights.com/checkout/9669
More Valuable Insights Available
Future Market Insights offers an unbiased global nonvascular interventional radiology device market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034.
The market is segmented by Type (Puncture and Drainage Methods and Needle Biopsy), Application (Benign Tumors, Uterine Fibroids, and Live and pancreatic Conditions), and Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and The Middle East and Africa).
Leading Nonvascular Interventional Radiology Device Brands
Carestream Health Inc.
Hologic Inc.
GE Healthcare
Fujifilm Corporation
Samsung Healthcare (Samsung Electronics Co. Ltd.)
Shimadzu Corporation
Siemens Healthineers
Canon Medical Systems Corporation
Olympus Corporation
What are the Key Features that Drive the Nonvascular Interventional Radiology Devices Market?
Cancer treatments have relied on the demand for nonvascular interventional radiology devices over the years.
The rapid growth of benign tumors, uterine fibroids, and innumerable live and pancreatic conditions will aid in the sales of nonvascular interventional radiology devices across lands throughout the forecast period.
Amplifying government support and several ongoing types of research are said to inspire market growth for nonvascular interventional radiology devices during the forecast period.
The forecast period calls for growing awareness of the adoption of nonvascular interventional radiology devices across regions.
What are the Restraints that Hinder the Nonvascular Interventional Radiology Devices Market?
High costs associated with the sales of nonvascular interventional radiology devices and other radiology procedures are presumed to thwart the market growth during the forecast period.
Bleeding or infections can be a direct risk for consumers seeking the adoption of nonvascular interventional radiology devices, which can seriously hamper the market growth.
What are the Possibilities that could Expand the Nonvascular Interventional Radiology Devices Market?
Reduced complications are a certainty with regard to biopsies if precise tissue sampling is improved with the development of finer needles, precise image guiding, and automatic biopsy guns.
Nonvascular interventions are executed using image-guided biopsies and drainages, which demand nonvascular interventional radiology devices.
Research institutes implementing extensive research on the nonvascular interventional radiology devices market share is guaranteed to boost demand by the end-user segment.
The leading segment by product type is nonvascular interventional radiology devices, and it is gaining marketability for tumor therapies, over the years.
Nonvascular Interventional Radiology Device Market - Key Segments
By Type:
The ecosystem can be classified based on the device type into Puncture and Drainage Methods and Needle Biopsy.
By Application:
Based on the application, the sector can be segmented into Benign Tumours, Uterine Fibroids, and Live and pancreatic Conditions.
By Region:
North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and The Middle East and Africa are the key contributing regions to the industry.
Report Preview: https://www.futuremarketinsights.com/reports/nonvascular-interventional-radiology-devices-market
Author by
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at the Related Report from the Nonvascular Interventional Radiology Device Market:
The global radiology information system RIS market was valued at around US$ 1.0 Billion at the end of 2021. The market is projected to register a 7.9% CAGR and top a valuation of US$ 2.2 Billion by 2032.
The global radio frequency beauty equipment market share is projected to be US$ 1,947.8 million by 2033. Radio frequency beauty equipment suppliers expect the market to expand at a CAGR of 17.8% through 2033.
The global portable medical devices market is projected to expand at a CAGR of 10.7% during the forecast period. The market is estimated to generate market revenue of US$ 163.84 billion by 2033, increasing from US$ 59.28 billion in 2023.
The valuation of the teleradiology market is estimated to be US$ 7,567.50 million in 2023. The market was valued at US$ 6,489.20 million in 2022. The market is projected to show outstanding growth over the forecast period
The global Teleradiology Service Market size is projected to surpass a valuation of US$ 22,069.5 million by 2033. Our healthcare analysts opine that tele radiology service providers can expect a stunning CAGR of 12.20% through 2033
The Global interventional radiology demand is forecast to reach US$ 42.7 Billion and grow at 5% CAGR. The cost-effectiveness of minimally-invasive procedures and shorter hospital stays are driving a growing trend of minimally-invasive procedures
The telehealth kiosk market is valued at US$ 2,060.50 million in 2024 and is expected to rise at a stable CAGR of around 7.20% over the forecast period.
The veterinary telehealth market is anticipated to be worth US$ 190.8 million in 2024. The primary focus is veterinary telehealth and disease detection, which can characterize the rise in management system adoption.
The telehealth and telemedicine market is predicted to capture a valuation of US$ 106.0 billion in 2023 and rise to US$ 912.0 billion by 2033. The market is estimated at a CAGR of 24% during the forecast period.
The global Medical Telepresence Robots market is estimated at US$ 61.1 Million in 2022 and is projected to reach a valuation of US$ 459.1 Million by 2032, expanding at a CAGR of 22.5%
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube
SOURCE: Future Market Insights Inc.
View the original press release on accesswire.com
